Analyst stock forecast
Recursion Pharmaceuticals, Inc. - Class A Common Stock Stock Forecast and Analyst Price Target
RXRX analyst target range, upside, consensus rating and coverage count.
Direct answer
Recursion Pharmaceuticals, Inc. - Class A Common Stock's average price target is $7.25.
The target implies +116.4% from the recorded current price, and the consensus rating is Buy.
The verified range is $4.00 to $10.00, with 6 analysts in the current consensus when available.
Forecast evidence checked August 11, 2026.
Get free Recursion Pharmaceuticals, Inc. - Class A Common Stock email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.35
- Average price target
- $7.25
- High price target
- $10.00
- Low price target
- $4.00
- Target upside
- +116.4%
- Consensus rating
- Buy
- Analysts
- 6
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026
Explore related company data
View Recursion Pharmaceuticals, Inc. - Class A Common Stock's price target rangeView Recursion Pharmaceuticals, Inc. - Class A Common Stock's target upside or downsideView Recursion Pharmaceuticals, Inc. - Class A Common Stock's analyst consensus ratingReturn to Recursion Pharmaceuticals, Inc. - Class A Common Stock profile